CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.
OBJECTIVE
To investigate the infectivity of T-helper (Th)1 and Th2 cells (derived from ccr5 wild-type and homozygous ccr5 Delta 32) to R5 and X4 HIV-1.


METHODS
It remains unclear whether infection of Th1 and Th2 CD4 cells by R5 and X4 viruses mirrors their co-receptor expression profile as no direct quantitation of coreceptor levels and infection has been performed. In addition, it is unknown whether the lack of CCR5 expression affects the degree of Th1/Th2 polarization.


METHODS
Surface expression of CCR5 and CXCR4 was determined by quantitative fluorescence activated cell sorter analysis on in vitro differentiated Th1 and Th2 cells. R5 (Ba-L) and X4 (IIIB) HIV-1 isolates were used for infection studies and the efficiency of viral entry was determined by quantitative real time polymerase chain reaction detection of reverse transcribed proviral DNA.


RESULTS
Cell surface density of CCR5 molecules was eight-fold higher in Th1 versus Th2 subsets (P = 0.005) whereas CXCR4 surface density was four-fold higher in Th2 versus Th1 subsets (P = 0.006). Preferential infection and entry of Th1 cells by R5 HIV-1 was not associated with preferential replication, as eventually the R5-virus replicated to a higher level in Th2 cells in spite of lower initial viral infection/entry. By contrast, Th2 cells preferentially supported X4-virus infection and replication. High beta chemokine secretion by Th1 cells was associated with a lower R5 replication rate.


CONCLUSIONS
Th1 and Th2 cells differ in their infection efficiency for R5 and X4 HIV-1. ccr5 Delta 32-homozygous individuals maintain the ability for Th1/Th2 polarization, i.e., the expression of CCR5 is not required for Th1/Th2 polarization.
Moonis
M
M
Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Lee
B
B
Bailer
R T
RT
Luo
Q
Q
Montaner
L J
LJ
D002460:Cell Line; D016764:Cell Polarity; D019742:Chemokines, CC / Q000378:metabolism; D004279:DNA, Viral / Q000097:blood; D015497:HIV-1 / Q000145:classification / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D019713:Receptors, CCR5 / Q000378:metabolism*; D019718:Receptors, CXCR4 / Q000378:metabolism*; D018417:Th1 Cells / Q000378:metabolism / Q000821:virology*; D018418:Th2 Cells / Q000378:metabolism / Q000821:virology*; D014779:Virus Replication
D019742:Chemokines, CC; D004279:DNA, Viral; D012333:RNA, Messenger; D019713:Receptors, CCR5; D019718:Receptors, CXCR4